Consistent with our findings, both CHI3L1 and CHI3L2 have been shown to drive proliferation in a variety of human cell types [18,20–23,30] in addition to being associated with numerous chronic inflammatory diseases and cancers including glioblastoma, non-small cell lung cancer and colon cancer. Here, CHI3L2 is linked to cancer.